2018
DOI: 10.1007/s12288-018-0940-2
|View full text |Cite
|
Sign up to set email alerts
|

Acral Hyperpigmentation Resulting from Hydroxyurea Therapy in Primary Myelofibrosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
4

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 2 publications
0
2
0
Order By: Relevance
“…Medications frequently reported with melanonychia are hydroxyurea, zidovudine, and psoralen. 1,9,10 For onycholysis, other medications are tetracyclines, psoralen, and nonsteroidal antiinflammatory drugs. 1 Retinoids, indinavir, methotrexate, capecitabine, sirolimus, and epidermal growth factor receptor inhibitors reported paronychia and pyogenic granuloma.…”
Section: Discussionmentioning
confidence: 99%
“…Medications frequently reported with melanonychia are hydroxyurea, zidovudine, and psoralen. 1,9,10 For onycholysis, other medications are tetracyclines, psoralen, and nonsteroidal antiinflammatory drugs. 1 Retinoids, indinavir, methotrexate, capecitabine, sirolimus, and epidermal growth factor receptor inhibitors reported paronychia and pyogenic granuloma.…”
Section: Discussionmentioning
confidence: 99%
“…Other nail changes described in Kawasaki disease include transverse leukonychia, Beau's lines, onychomadesis, and pincer nails . Transverse orange‐brown chromonychia may also result particularly from chemotherapy, for example, with hydroxyurea …”
Section: Differential Diagnosismentioning
confidence: 99%